Biotech
10x Genomics
10x Genomics raises $55M Series E at $500M valuation
Pleasanton, CAJanuary 10, 20181 min read
Total Raised
$55M
Valuation
$500M
Latest Round
Series E
Employees
800+
10x Genomics: Series E Funding Round
10x Genomics has successfully raised $55M in Series E funding, reaching a valuation of $500M.
Company Overview
Single-cell genomics and spatial biology
Funding Details
The Series E round was led by Softbank Vision Fund, with participation from Fidelity.
Company Information
- Headquarters: Pleasanton, CA
- Founded: 2012
- Employees: 800+
- Category: Biotech
Investment
10x Genomics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Softbank Vision Fund: Verified investor in Series E
- Fidelity: Verified investor in Series E
Company Info
Headquarters
Pleasanton, CA
Founded
2012
Team Size
800+
Last Round
$55M(Jan 2018)
Investors (2)
S
Softbank Vision FundLeadLead Investor
Verified investor in Series E
F
FidelityInvestor
Verified investor in Series E
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free